PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 13666992

Atheromatous embolization; a factor in peripheral gangrene.

S J HOYE·S TEITELBAUM·I GORE·R WARREN
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Arteriosclerosis ObliteransCardiovascular SystemEmbolismEmbolization, TherapeuticGangreneHumansPlaque, AtheroscleroticSkinARTERIOSCLEROSIS OBLITERANS/complicationsEMBOLISM/complicationsGANGRENE/etiology and pathogenesisSKIN/blood supplyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S J HOYE, S TEITELBAUM, I GORE, R WARREN. 1959-07-16. Atheromatous embolization; a factor in peripheral gangrene.. https://doi.org/10.1056/nejm195907162610305

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

[Overview on diagnosis, treatment and therapeutic angiogenesis for arteriosclerosis obliterans].

Arteriosclerosis of the extremities is a disease of the blood vessels characterized by hardening and/or narrowing of the arteries that supply the legs and feet. This causes a decrease in blood flow that can injure nerves and other tissues. Therapeutic angiogenesis using angiogenic growth factor is expected to be a new treatment for patients with critical limb ischemia. The first human clinical trial treating peripheral vascular disease was started in 1994 using vascular endothelial growth factor. To date, other potent angiogenic growth factors, such as hepatocyte growth factor(HGF), have been also estimated in clinical trials for peripheral arterial disease. Several results from phase 1 or 2 trials using HGF gene were encouraging. Phase 3 trials are now ongoing and their results are expected.

Arteriosclerosis Obliterans↗
PubMed2005

Ischemic duodenitis.

Explore the source record for details and available documents.

Arteriosclerosis Obliterans↗